(Q24245704)

1

0 references

D Nikolova

2

0 references

RG Simonetti

3

0 references

C Gluud

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 October 2004

0 references

published in

0 references

cites work

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Helicobacter pylori seropositivity as a risk factor for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Postintervention effect of alpha tocopherol and beta carotene on different strokes: a 6-year follow-up of the Alpha Tocopherol, Beta Carotene Cancer Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Evidence for excess colorectal cancer incidence among asbestos-exposed men in the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Stopping the active intervention: CARET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Changes in cholesterol and triglyceride concentrations in the Vanguard population of the Carotene and Retinol Efficacy Trial (CARET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Predictors of lung cancer among asbestos-exposed men in the {beta}-carotene and retinol efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Serum trans-fatty acids are associated with risk of prostate cancer in beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

CARET study: women included

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Streamlining IRB review in multisite trials through single-study IRB Cooperative Agreements: experience of the Beta-Carotene and Retinol Efficacy Trial (CARET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Participation and Adherence Among Older Men and Women Recruited to the Beta-Carotene and Retinol Efficacy Trial (CARET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Research cost analyses to aid in decision making in the conduct of a large prevention trial, CARET. Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Mailing strategies and costs of recruiting heavy smokers in CARET, a large chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effect of long-term therapy with ramipril in high-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The HOPE TIPS: the HOPE study translated into practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Benefits of simvastin in cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus. Randomised double-blind intervention study in high-risk population of China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Impact of selenium and cancer-prevention findings on the nutrition-health paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Reduction of cancer mortality and incidence by selenium supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Involvement of polyamines in selenomethionine induced apoptosis and mitotic alterations in human tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Interobserver agreement in the classification of stroke in the physicians' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Baseline self-reported cataract and subsequent mortality in Physicians' Health Study I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized trial of aspirin and beta-carotene among U.S. physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The Physician's Health Study. A neurologist's concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Estimating the effect of the run-in on the power of the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: The Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Male Pattern Baldness and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dietary intakes and food sources of n-6 and n-3 PUFA in French adult men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Use of 'light' foods and drinks in French adults: biological, anthropometric and nutritional correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Consumption of soup and nutritional intake in French adults: consequences for nutritional status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Impact of cancer occurrence on health-related quality of life: a longitudinal pre-post assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Consequences of iron depletion on health in menstruating women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Relationship between soup consumption, folate, beta-carotene, and vitamin C status in a French adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Serum concentrations of beta-carotene, vitamins C and E, zinc and selenium are influenced by sex, age, diet, smoking status, alcohol consumption and corpulence in a general French adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Comparison of the diet of self-declared diabetics with non-diabetic patients in the SU.VI.MAX study: did the diabetics modify their nutritional behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Alterations of the lipid profile after 7.5 years of low-dose antioxidant supplementation in the SU.VI.MAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Minéraux AntioXydants (SU.VI.MAX) adult cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Alcohol intake in relation to body mass index and waist-to-hip ratio: the importance of type of alcoholic beverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Seroprevalence of HSV-1 and HSV-2 infection in the general French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Epidemiologic determinants of skin photoaging: baseline data of the SU.VI.MAX. cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The use of computerised 24 h dietary recalls in the French SU.VI.MAX Study: number of recalls required.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Alcohol and atherosclerotic vascular disease risk factors in French men: relationships are linear, J-shaped, and U-shaped

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Drinking patterns in French adult men--a cluster analysis of alcoholic beverages and relationship with lifestyle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Leisure time physical activity and health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of long-term daily low-dose supplementation with antioxidant vitamins and minerals on structure and function of large arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Comparison of self-reported diagnosis of connective tissue disease with medical records in female health professionals: the Women's Health Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: is the association modified by baseline plasma level?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized trial of ascorbic acid in polyposis coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Diet and risk of cancer of the upper aerodigestive tract--II. Nutrients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Diet and risk of cancer of the upper aerodigestive tract--I. Foods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vegetables, fruits, related dietary antioxidants, and risk of squamous cell carcinoma of the esophagus: a case-control study in Uruguay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Interventional trial for colorectal cancer prevention in Osaka: an introduction to the protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dietary fiber and plant foods in relation to colorectal cancer mortality: the Seven Countries Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Selected micronutrients and colorectal cancer. a case-control study from the canton of Vaud, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Wheat bran fiber and development of adenomatous polyps: evidence from randomized, controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The aging/precancerous gastric mucosa: a pilot nutraceutical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Plasma selenium levels and the risk of colorectal adenomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Lack of long-term effect of vitamin C supplementation on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effect of five-year supplementation of vitamin C on serum vitamin C concentration and consumption of vegetables and fruits in middle-aged Japanese: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of three-month oral supplementation of beta-carotene and vitamin C on serum concentrations of carotenoids and vitamins in middle-aged subjects: a pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese p

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized controlled trial for chemoprevention of gastric cancer in high-risk Japanese population; study design, feasibility and protocol modification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A pilot study for a randomized controlled trial to prevent gastric cancer in high-risk Japanese population: study design and feasibility evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Accumulation and interactions of beta-carotene and alpha-tocopherol in patients with adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A population-based dietary intervention trial in a high-risk area for stomach cancer and stroke: changes in intakes and related biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

A randomized, controlled chemoprevention trial of selenium in familial prostate cancer: Rationale, recruitment, and design issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Selenium and vitamin E cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

SELECT: the selenium and vitamin E cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The causes and prevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Descriptive epidemiology of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Nutrition and esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Selenium in forage crops and cancer mortality in U.S. counties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Antioxidants and disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Review: When is an antioxidant not an antioxidant? A review of novel actions and reactions of vitamin C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Fruit and vegetable intake and esophageal cancer in a large prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Association between unreported outcomes and effect size estimates in Cochrane meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of gastrointestinal malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Bias in clinical intervention research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The culture of designing hepato-biliary randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention in gastrointestinal cancers: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Epidemiology and pathogenesis of esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Cell death at the millennium. Implications for liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Fruit and vegetable consumption and incidence of gastric cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Beneficial and adverse effects of chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Essential nutrients: food or supplements? Where should the emphasis be?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Epidemiology and risk factors for pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The genetic pathogenesis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Pathogenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Analysis and reporting of factorial trials: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The Food Standards Agency's antioxidants in food programme--a summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Systematic review: the chemoprevention of oesophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Oxidative DNA damage by vitamin A and its derivative via superoxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

For my wellness, not just my illness: North Americans' use of dietary supplements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Fruits, vegetables, and antioxidants and risk of gastric cancer among male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index for endogenous nitrosation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Beta-carotene: a cancer chemopreventive agent or a co-carcinogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

From selenium to selenoproteins: synthesis, identity, and their role in human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dysregulation of apoptosis as a mechanism of liver disease: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Can dietary beta-carotene materially reduce human cancer rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vitamin C exhibits pro-oxidant properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Colorectal cancer: molecules and populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The importance of selenium to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Selenium in cancer prevention: a review of the evidence and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Does oxidative stress participate in the development of hepatocellular carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Cancer mortality correlation studies--IV: associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vitamin supplementation: what the gastroenterologist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Oxidative stress has a role in malignant transformation in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Prospects for chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Nutritional supplements and conventional medicine; what should the physician know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Antioxidants and prevention of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Outcome selection bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Keap1 eye on the target: chemoprevention of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Carotene and Retinol Efficacy Trial: Lung Cancer Chemoprevention Trial in Heavy Cigarette Smokers and Asbestos-exposed Workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Sun-reactive Skin Type in 4912 French Adults Participating in the SU.VI.MAX Study¶

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of Primary Liver Cancer: A Randomized, Double-Blind Trial in Linxian, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Fruits, Vegetables, and Colon Cancer Risk in a Pooled Analysis of 14 Cohort Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Chemoprevention of Precancerous Gastric Lesions With Antioxidant Vitamin Supplementation: A Randomized Trial in a High-Risk Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Combined Antioxidant Therapy Reduces Pain and Improves Quality of Life in Chronic Pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

Vitamin and mineral supplement use in the United States. Results from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Migraine and subsequent risk of stroke in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Cigarette smoking and risk of prostate cancer in the physicians' health study (United States)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The effect of vitamin and mineral supplementation on esophageal cytology: results from the Linxian Dysplasia Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Diet and risk of esophageal cancer by histologic type in a low-risk population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Lobe of origin and histologic type of lung cancer associated with asbestos exposure in the carotene and retinol efficacy trial (CARET)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Cost and efficiency in clinical trials: the U.S. Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The selenium and vitamin E cancer prevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Prevention of liver cancer: current strategies and future perspectives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Methodologic considerations in the design and conduct of randomized trials: the U.S. Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Vitamin A, Vitamin E or beta-carotene status and hepatitis B-related hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: The 1987, 1992, and 2000 National Health Interview Survey results

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Contribution of mineral waters to dietary calcium and magnesium intake in a French adult population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The value of antioxidant supplements vs their natural counterparts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The nature of prooxidant activity of vitamin C

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Comparison of baseline characteristics and mortality experience of participants and nonparticipants in a randomized clinical trial: the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Indicators of abdominal adiposity in middle-aged participants of the SU.VI.MAX study: relationships with educational level, smoking status and physical inactivity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Factors determining the use of hormone replacement therapy in recent naturally postmenopausal women participating in the French SU.VI.MAX cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Use of multiple correspondence analysis and cluster analysis to study dietary behaviour: food consumption questionnaire in the SU.VI.MAX. cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Physical activity and risk of colon cancer: the Physicians' Health Study (United States)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Retinal vascular changes following supplementation with alpha-tocopherol or beta-carotene

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Relationships between changes in weight and changes in cardiovascular risk factors in middle-aged French subjects: effect of dieting

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Determinants of thyroid volume in healthy French adults participating in the SU.VI.MAX cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Chemoprevention of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Baseline Characteristics of Participants in the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The antioxidant supplement myth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Effect of nutrition intervention on intermediate endpoints in esophageal and gastric carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The Linxian trials: mortality rates by vitamin-mineral intervention group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Implementation of a 4-y, high-fiber, high-fruit-and-vegetable, low-fat dietary intervention: results of dietary changes in the Polyp Prevention Trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

What is known about the safety of multivitamin-multimineral supplements for the generally healthy population? Theoretical basis for harm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Adverse event monitoring and multivitamin-multimineral dietary supplements

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Workplace air-conditioning and health services attendance among French middle-aged women: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

A review of epidemiologic evidence that carotenoids reduce the risk of cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The dual roles of nutrients as antioxidants and prooxidants: their effects on tumor cell growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Vitamin nutrition and gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Consumption of foods rich in flavonoids is related to a decreased cardiovascular risk in apparently healthy French women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

A factorial trial including garlic supplements assesses effect in reducing precancerous gastric lesions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Effect of wheat fiber and vitamins C and E on rectal polyps in patients with familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Beta carotene fails to prevent cancer in two major studies; CARET intervention stopped

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Re: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Lifetime cigarette smoking and colorectal cancer incidence in the Physicians' Health Study I

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Prospective study of serum selenium levels and incident esophageal and gastric cancers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Fish consumption and cardiovascular disease in the physicians' health study: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Self-administered questionnaire compared with interview to assess past-year physical activity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Contribution of ready-to-eat cereals to nutrition intakes in French adults and relations with corpulence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Plasma levels of retinol in cancer patients supplemented with retinol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

The G20210A prothrombin mutation and the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Tomatoes, lycopene intake, and digestive tract and female hormone-related neoplasms

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Sociodemographic and geographic correlates of meeting current recommendations for physical activity in middle-aged French adults: the Supplémentation en Vitamines et Minéraux Antioxydants (SUVIMAX) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Confirmation of self-reported cataract in the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021

Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004183.PUB2

7 January 2021